Cheetah Medical Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
120
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$215M
Cheetah Medical General Information
Description
Developer of noninvasive hemodynamic monitoring technologies designed to manage the patient's fluid status. The company's technologies develop and commercialize a non-invasive treatment for monitoring of critically ill patients which use a proprietary algorithm to calculate hemodynamic parameters to assess heart function, enabling doctors to make more confident and informed treatment decisions that support the clinical goals of improving patient outcomes and driving economic efficiencies.
Contact Information
Website
cheetah-medical.comCorporate Office
- 1320 Centre Street
- Suite 401
- Newton Center, MA 02459
- United States
Corporate Office
- 1320 Centre Street
- Suite 401
- Newton Center, MA 02459
- United States
Cheetah Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 25-Oct-2019 | $215M | Completed | Generating Revenue | ||
| 9. Later Stage VC | 27-Feb-2019 | Completed | Generating Revenue | |||
| 8. Debt Refinancing | 14-Feb-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C1) | 20-Apr-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 17-May-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 06-Jun-2014 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2012 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 15-Nov-2011 | Completed | Generating Revenue | |||
| 2. Debt - General | 21-Sep-2011 | $4M | $22.7M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series AA) | $18.7M | $18.7M | Completed | Generating Revenue |
Cheetah Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B1 | 74,893,837 | $0.000100 | 6% | $0.28 | $0.57 | 2x | $0.28 | 22.15% |
| Series A1 | 92,070,860 | $0.000100 | 6% | $0.26 | $0.26 | 1x | $0.26 | 27.23% |
Cheetah Medical Comparisons
Industry
Financing
Details
Cheetah Medical Competitors (5)
One of Cheetah Medical’s 5 competitors is Mespere Lifesciences, a Accelerator/Incubator Backed company based in Waterloo, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mespere Lifesciences | Accelerator/Incubator Backed | Waterloo, Canada | ||||
| Masimo | Formerly PE-Backed | Irvine, CA | ||||
| iRhythm Holdings | Formerly VC-backed | San Francisco, CA | ||||
| Retia Medical | Venture Capital-Backed | White Plains, NY | ||||
| Finapres Medical Systems | Corporate Backed or Acquired | Enschede, Netherlands |
Cheetah Medical Patents
Cheetah Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2854622-A1 | Method and system for assessing likelihood of sepsis | Inactive | 05-Jun-2012 | ||
| WO-2013183001-A1 | Method and system for assessing likelihood of sepsis | Inactive | 05-Jun-2012 | ||
| AU-2012288416-A1 | Method and system for monitoring hemodynamics | Active | 25-Jul-2011 | ||
| AU-2012288416-B2 | Method and system for monitoring hemodynamics | Active | 25-Jul-2011 | ||
| AU-2017201920-A1 | Method and system for monitoring hemodynamics | Inactive | 25-Jul-2011 | A61B5/0205 |
Cheetah Medical Signals
Cheetah Medical Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascension Ventures | Corporate Venture Capital | Minority | ||
| Bosch Ventures | Corporate Venture Capital | Minority | ||
| Eastward Capital Partners | Venture Capital | Minority | ||
| Fletcher Spaght Ventures | Venture Capital | Minority | ||
| HighCape Capital | Growth/Expansion | Minority |
Cheetah Medical FAQs
-
When was Cheetah Medical founded?
Cheetah Medical was founded in 2001.
-
Where is Cheetah Medical headquartered?
Cheetah Medical is headquartered in Newton Center, MA.
-
What is the size of Cheetah Medical?
Cheetah Medical has 120 total employees.
-
What industry is Cheetah Medical in?
Cheetah Medical’s primary industry is Monitoring Equipment.
-
Is Cheetah Medical a private or public company?
Cheetah Medical is a Private company.
-
What is the current valuation of Cheetah Medical?
The current valuation of Cheetah Medical is .
-
What is Cheetah Medical’s current revenue?
The current revenue for Cheetah Medical is .
-
How much funding has Cheetah Medical raised over time?
Cheetah Medical has raised $134M.
-
Who are Cheetah Medical’s investors?
Ascension Ventures, Bosch Ventures, Eastward Capital Partners, Fletcher Spaght Ventures, and HighCape Capital are 5 of 9 investors who have invested in Cheetah Medical.
-
Who are Cheetah Medical’s competitors?
Mespere Lifesciences, Masimo, iRhythm Holdings, Retia Medical, and Finapres Medical Systems are competitors of Cheetah Medical.
-
When was Cheetah Medical acquired?
Cheetah Medical was acquired on 25-Oct-2019.
-
Who acquired Cheetah Medical?
Cheetah Medical was acquired by Baxter International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process